Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III … – PR-CANADA.net (press release)

posted on Dec 28 by in the Uncategorized category

Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III ...
PR-CANADA.net (press release)
[2] * Tekturna/Rasilez (aliskiren) - a first-in-class direct renin inhibitor approved for treatment of hypertension that is also currently in Phase III ...

and more »

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes